Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44)
| Jurisdiction: | Federal |
| Incentive Type: | Grant Program |
| Industries: | Medical, Technology, Health And Safety, Food |
| Eligible Sector: | Business |
| Category: | Financial Incentive |
| Time Period: | FY 2015 |
| Governing Body: | National Institutes of Health |
| What’s it worth?: | $2,500,000 |
The Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring program was designed to fund the development of cutting edge technologies designed to be used for long-term, automated, wearable, glucose regulation. Ideal projects include:
- Glucose sensors and pancreatic hormones delivery systems
- Algorithms and Integrated Systems
- Pre-Clinical and Clinical research trials
There are three types of applications allowed: New proposals (Phase I), Renewal grants (Phase II) and Resubmission applications. Typical award amounts of not more than $225,000 for Phase I projects and up to $1,500,000 for Phase II projects with project duration of up to two years. All applicants must meet the following criteria:
